ATC Abstracts

American Transplant Congress abstracts

2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions
View by Date

Tuesday, May 5, 2015

5:30pm-6:30pm
Association Between Polymorphisms of PPM1E Gene and Tumor Size of Hepatocellular Carcinoma Patients

M.-S. Park,1 S.-K. Kim.2

Poster Session D: Liver Transplantation for Hepatocellular Carcinoma  •  Exhibit Hall E
5:30pm-6:30pm
Association of Transplant Volume and Survival in Pediatric Kidney Transplants

W. Cherikh,1 A. Wilk,1 C. Flavin,1 E. Brewer.2

Poster Session D: Pediatric Clinical Kidney Transplantation  •  Exhibit Hall E
5:30pm-6:30pm
Associations Between Sirolimus Use and Outcomes After Liver Transplant for Hepatocellular Carcinoma

E. Yanik,1 S. Chinnakotla,2 A. Israni,2,3 J. Snyder,2,3 S. Gustafson,3 E. Engels.1

Poster Session D: Liver Transplantation for Hepatocellular Carcinoma  •  Exhibit Hall E
5:30pm-6:30pm
Attenuating Racial Disparities in Kidney Transplantation Through the Use of Potent Immunosuppression Regimens

D. Taber, M. Gebregziabher, N. Pilch, T. Srinivas, K. Chavin, P. Baliga, L. Egede.

Poster Session D: Disparities in Healthcare Outcomes  •  Exhibit Hall E
5:30pm-6:30pm
Boosting the Adaptive Immune Response Prevents the High Incidence of Herpes Zoster After Lung or Heart Transplantation

N. van Besouw,1 S. Roest,2 J. Zuijderwijk,1 R. de Kuiper,1 J. van Weezel,3 A. van der Eijk,4 W. Weimar,1 P. Hal,3 O. Manintveld.2

Poster Session D: Viral Infections  •  Exhibit Hall E
5:30pm-6:30pm
Calcineurin (CNI) Exposure Reduces the Risk of Post-Transplant DSA After Deceased Donor Kidney Transplantation

R. Pelletier, A. Rajab, G. Bumgardner, M. Henry.

Poster Session D: Donor Specific Antibodies/Antibody Mediated Rejection  •  Exhibit Hall E
5:30pm-6:30pm
Calcineurin Inhibitor-Free Immunossupresion After Kidney Transplantation, Using Everolimus De Novo – Single Center Experience

M. Stronka, Z. Adamska, L. Cichanska, J. Kubiak, M. Gamrat, M. Karczewski.

Poster Session D: Kidney Immunosuppression: Drug Minimization  •  Exhibit Hall E
5:30pm-6:30pm
Calcineurin Inhibitors (CNI) Minimization Associated With Mammalian Target of Rapamycin Inhibitors (i-mTOR) to Improve Renal Function in Renal Grafts from Uncontrolled Donation After Cardiac Death Donors (UDCDD)

M. Molina,1 E. Gutierrez,1 S. González-Sanchidrian,2 E. González,1 J. Cabrera,1 N. Polanco,1 A. Hernández,1 A. Sevillano,1 M. Praga,1 A. Andres.1

Poster Session D: Kidney Immunosuppression: Drug Minimization  •  Exhibit Hall E
5:30pm-6:30pm
Calcineurin-Inhibitor Conversion to mTOR Inhibitor in Renal Transplant Recipients Leads to Worse Long Term Clinical Outcomes

A. Alvarado,1 A. Shetty,1 O. Traitanon,1 J. Leventhal,1 V. Mas,2 D. Chhabra,3 J. Matthews,1 L. Gallon.1

Poster Session D: Kidney Immunosuppression: Drug Minimization  •  Exhibit Hall E
5:30pm-6:30pm
Can Gene-Expression Profiling Score Help Explain the Adverse Clinical Outcomes Seen in Gender-Mismatched Heart Transplants?

N. Sulemanjee,1 P. Prasad,2 T. Wolf,2 V. Thohan,1 J. Teuteberg.3

Poster Session D: "The Tell-Tale Heart": Allograft Rejection and Post-Transplant Monitoring  •  Exhibit Hall E